AMTX
Aemetis, Inc.
NasdaqGMUSDEQUITY
Basic Materials
DELAYED
Last price
2.07
▲ 0.15 (7.81%)
MARKET · —
Price
Open
1.93
Prev close
1.92
Day high
2.10
Day low
1.93
Volume
1.15M
Market cap
$149.39M
P/E (TTM)
—
52W range
1.30 – 3.80
Trailing performance
Returnvs SPY
1W
+16.95%
+18.3%
1M
+11.89%
+8.2%
3M
-8.00%
-11.1%
6M
+40.82%
+29.8%
YTD
+48.92%
+36.6%
1Y
-15.16%
-35.2%
3Y
-64.31%
-138.5%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap$149.39M
Enterprise value$700.55M
Revenue (TTM)$230.17M
Gross profit$23.94M
EBITDA$-1.58M
Net income$-60.16M
EPS (TTM)$-0.86
Free cash flow$-65.83M
Total cash$973.00K
Total debt$552.13M
Book value / share$-4.47
Shares outstanding72.17M
Float67.16M
Short % of float12.94%
Dividend yield—
Beta (5Y)1.44
Valuation & profitability ratios
Trailing P/E—
Forward P/E-4.20
PEG ratio—
Price / sales—
Price / book—
EV / revenue3.04
EV / EBITDA-444.23
Gross margin10.40%
Operating margin9.21%
Profit margin-26.14%
Return on equity—
Return on assets-2.73%
Debt / equity—
Current ratio0.08
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total revenue | $197.63M | $267.64M | $186.72M | $256.51M |
| Cost of revenue | $0 | $0 | $0 | $0 |
| Gross profit | $0 | $0 | $0 | $0 |
| R&D | — | — | — | — |
| SG&A | — | — | — | — |
| Operating income | — | — | — | — |
| Pre-tax income | — | — | — | — |
| Tax provision | $0 | $0 | $0 | $0 |
| Net income | -$77.00M | -$87.54M | -$46.42M | -$107.76M |
| EBIT | $0 | $0 | $0 | $0 |
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Cash & equivalents | — | — | — | — |
| Short-term investments | — | — | — | — |
| Net receivables | — | — | — | — |
| Inventory | — | — | — | — |
| Total current assets | — | — | — | — |
| Total assets | — | — | — | — |
| Total current liabilities | — | — | — | — |
| Long-term debt | — | — | — | — |
| Total liabilities | — | — | — | — |
| Retained earnings | — | — | — | — |
| Shareholder equity | — | — | — | — |
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$77.00M | -$87.54M | -$46.42M | -$107.76M |
| Depreciation | — | — | — | — |
| Change in working capital | — | — | — | — |
| Operating cash flow | — | — | — | — |
| Capital expenditure | — | — | — | — |
| Investing cash flow | — | — | — | — |
| Dividends paid | — | — | — | — |
| Buybacks | — | — | — | — |
| Financing cash flow | — | — | — | — |
| Net change in cash | — | — | — | — |
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | -0.24 | -0.11 | +54.8% |
| Mar 2026 | -0.20 | -0.30 | -47.1% |
| Dec 2025 | -0.22 | -0.09 | +61.2% |
| Sep 2025 | -0.21 | -0.37 | -77.3% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | -0.17 | 3 | $69.74M | +17.8% |
| Next quarter | -0.17 | 3 | $69.39M | +60.2% |
| Current year | -0.81 | 3 | $256.43M | +29.8% |
| Next year | -0.49 | 3 | $380.89M | +48.5% |
Analyst targets & ownership
Mean target$13.38
High target$28.00
Low target$2.50
Implied upside546.14%
Analyst count4
ConsensusSTRONG BUY
Strong buy / Buy0 / 3
Hold1
Sell / Strong sell0 / 0
Held by insiders6.95%
Held by institutions24.62%
Institutions holding112
Price targets, consensus spread, insider and institutional ownership.
Insider net activity
Net shares
+300.00K
Net buying
Buy transactions
2
310.00K shares
Sell transactions
1
10.00K shares
Net transactions
+3
Buys less sells
Sell : buy shares
0.0 : 1
Mixed
Insider-held shares
5.02M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Jun 10, 26 | SIMON TIMOTHY ALAN Director |
SELL | 10.00K | $20.50K | Direct |
| Mar 19, 26 | BLOCK JOHN R Director |
STOCK | 10.00K | $26.40K | Direct |
| Mar 19, 26 | MCAFEE ERIC A Chief Executive Officer |
STOCK | 300.00K | $792.00K | Direct |
| Jan 22, 26 | BLOCK JOHN R Director |
STOCK | 12.00K | $18.48K | Direct |
| Jan 22, 26 | BARTON FRANCIS P Director |
STOCK | 18.00K | $27.72K | Direct |
| Jan 22, 26 | BEEBE LYDIA I Director |
STOCK | 14.50K | $22.33K | Direct |
| Jan 22, 26 | BONESS NAOMI LOUISE Director |
STOCK | 12.00K | $18.48K | Direct |
| Jan 22, 26 | SIMON TIMOTHY ALAN Director |
STOCK | 12.00K | $18.48K | Direct |
| Aug 14, 25 | BARTON FRANCIS P Director |
SELL | 26.45K | $67.02K | Direct |
| May 15, 25 | ROCKETT JAMES MICHAEL General Counsel |
STOCK | 27.92K | $45.51K | Direct |
| Apr 7, 25 | WALTZ TODD Chief Financial Officer |
CONVERSION | 288.88K | $207.28K | Direct |
| Jan 16, 25 | BLOCK JOHN R Director |
STOCK | 12.00K | $0 | Direct |
| Jan 16, 25 | BARTON FRANCIS P Director |
STOCK | 18.00K | $0 | Direct |
| Jan 16, 25 | MCAFEE ERIC A Chief Executive Officer |
STOCK | 300.00K | $0 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BARTON FRANCIS P |
Director | 226.52K | Stock Award(Grant) |
BEEBE LYDIA I |
Director | 214.29K | Stock Award(Grant) |
BLOCK JOHN R |
Director | 56.33K | Stock Award(Grant) |
BONESS NAOMI LOUISE |
Director | 64.64K | Stock Award(Grant) |
MCAFEE ERIC A |
Chief Executive Officer | 3.92M | Stock Award(Grant) |
ROCKETT JAMES MICHAEL |
General Counsel | 27.92K | Stock Award(Grant) |
SIMON TIMOTHY ALAN |
Director | 42.63K | Sale |
WALTZ TODD |
Chief Financial Officer | 456.82K | Conversion of Exercise of derivative security |
Moving averages & technicals
SMA 10
1.81
+14.21% from price
SMA 20
1.68
+22.92% from price
SMA 50
1.71
+21.23% from price
SMA 100
2.16
-4.37% from price
SMA 200
1.95
+6.18% from price
EMA 12
1.82
+14.05% from price
EMA 26
1.75
+18.17% from price
EMA 50
1.81
+14.27% from price
RSI (14)
68.4
Neutral
MACD (12,26,9)
0.06
Hist 0.05
ATR (14)
0.12
5.98% of price
Realised vol 30D
82.1%
Annualised
Bollinger upper
2.01
20, 2σ
Bollinger lower
1.36
20, 2σ
50 / 200 cross
Death
1.71 vs 1.95
Trend bias
Above 200
+6.18%
Risk profile
Beta vs SPY
0.88
Less volatile than market
Correlation to SPY
0.12
Largely independent
Realised vol 30D
82.1%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-61.5%
Peak to trough
Max drawdown 5Y
-94.4%
Peak to trough
ATR 14
0.12
5.98% of price
Beta (reported)
1.44
5Y monthly, from filing
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Options analytics
Put / call volume
0.19
Call-heavy session
Put / call open interest
1.70
Positioning, not flow
Max pain
2.50
+20.8% from spot
ATM implied vol
83.6%
Nearest strike to spot
Skew (10% OTM)
-20.3%
Calls bid over puts
Call volume
81
Contracts, this expiry
Put volume
15
Contracts, this expiry
Heaviest call OI
2.00
12 contracts
Heaviest put OI
2.00
21 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Headlines
Can Alto Ingredients' Export Challenges Weigh on Growth Outlook?
Zacks · 5d ago
Aemetis (AMTX) Q2 2026 Earnings Call Transcript
Motley Fool · 9d ago
Stonegate Capital Partners Updates Coverage on Aemetis Inc. (AMTX) 2Q26
TMX Newsfile · 12d ago
Aemetis Inc (AMTX) (Q2 2026) Earnings Call Highlights: Revenue Surges 20% and 45Z Credit Sales ...
GuruFocus.com · 16d ago
Aemetis Q2 Earnings Call Highlights
MarketBeat · 16d ago
Aemetis (AMTX) Reports Q2 Loss, Misses Revenue Estimates
Zacks · 16d ago
Aemetis: Q2 Earnings Snapshot
Associated Press · 16d ago
Aemetis Reports Second Quarter 2026 Financial Results
GlobeNewswire · 16d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.